More articles from Volume 51, Issue 3, 2022
Anatomical and morphological characteristics of the appendix in acute appendicitis
Coronary sinus, microanatomical study
Analysis of the characteristics of traffic trauma
Understanding wedge resection research productivity with visualization: A scientometric attitude
Prevention of micronutrient deficiencies in the elderly
Obesity and consequent changes in the body
,
Bojana Kisić
,
Dragana Puhalo-Sladoje
,
Dijana Mirić
,
Dragiša Rašić
Tatjana Novaković
Abstract
References
1.
Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19·2 million participants. Vol. 387, The Lancet. 2016. p. 1377–96.
2.
Collaboration NCDRF. Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults. Vol. 390. 2017. p. 10 1016 0140-6736 17 32129-3.
3.
Ng M, Fleming T, Robinson M, Thomson B, Graetz N, C M, et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Vol. 384. 2014.
4.
Pekmezović T, Kisić Tepavčević D, Miljuš D, Marić G. Nacionalni podaci vezani za epidemiju gojaznosti u Srbiji. Epidemija gojaznosti u Srbiji. 2017.
5.
Cuschieri S, Mamo J. Getting to grips with the obesity epidemic in Europe. Vol. 4, SAGE Open Medicine. 2016. p. 205031211667040.
6.
Sipetic S, Bjegovic-Mikanovic V, Vlajinac H, Marinkovic J, Jankovic S, Terzic Z, et al. The burden of disease preventable by risk factor reduction in Serbia. Vol. 70, Vojnosanitetski pregled. 2013. p. 445–51.
7.
Kocarnik JM, Compton K, Dean FE, Fu W, Gaw BL, et al. Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019. Vol. 8, JAMA Oncology. 2022. p. 420.
8.
Roth GA, Mensah GA, Johnson CO, Addolorato G, Ammirati E, LM B, et al. Global Burden of Cardiovascular Diseases and Risk Factors, 1990-2019: Update From the GBD 2019 Study. Vol. 3021. 2020. p. 10 1016.
9.
Aziz T, Hussain N, Hameed Z, Lin L. Elucidating the role of diet in maintaining gut health to reduce the risk of obesity, cardiovascular and other age-related inflammatory diseases: recent challenges and future recommendations. Vol. 16, Gut Microbes. 2024.
10.
Meldrum DR, Morris MA, Gambone JC. Obesity pandemic: causes, consequences, and solutions—but do we have the will? Vol. 107, Fertility and Sterility. 2017. p. 833–9.
11.
Haberka M, Okopień B, Gąsior Z. Obesity, ultrasound indexes of fat depots and lipid goal attainment in patients with high and very high cardiovascular risk: A novel approach towards better risk reduction. Vol. 26, Nutrition, Metabolism and Cardiovascular Diseases. 2016. p. 123–33.
12.
Endalifer ML, Diress G. Epidemiology, Predisposing Factors, Biomarkers, and Prevention Mechanism of Obesity: A Systematic Review. Vol. 2020, Journal of Obesity. 2020. p. 1–8.
13.
Sierawska O, Sawczuk M. Interaction between Selected Adipokines and Musculoskeletal and Cardiovascular Systems: A Review of Current Knowledge. Vol. 24, International Journal of Molecular Sciences. p. 17287.
14.
Seth M, Biswas R, Ganguly S, Chakrabarti N, Chaudhuri AG. Leptin and obesity. Vol. 107, Physiology International. 2021. p. 455–68.
15.
Park HK, Ahima RS. Physiology of leptin: energy homeostasis, neuroendocrine function and metabolism. Vol. 64, Metabolism. 2015. p. 24–34.
16.
Obradovic M, Sudar-Milovanovic E, Soskic S, Essack M, Arya S, Stewart AJ, et al. Leptin and Obesity: Role and Clinical Implication. Vol. 12, Frontiers in Endocrinology.
17.
Mantzoros CS, Magkos F, Brinkoetter M, Sienkiewicz E, Dardeno TA, Kim SY, et al. Leptin in human physiology and pathophysiology. Vol. 301, American Journal of Physiology-Endocrinology and Metabolism. 2011. p. E567–84.
18.
Friedman JM. Leptin and the endocrine control of energy balance. Vol. 1, Nature Metabolism. p. 754–64.
19.
Sladoje DP, Kisić B, Mirić D. The Monitoring of Protein Markers of Inflammation and Serum Lipid Concentration in Obese Subjects with Metabolic Syndrome. Vol. 36, Journal of Medical Biochemistry. 2017. p. 366–74.
20.
Pérez-Pérez A, Vilariño-García T, Fernández-Riejos P, Martín-González J, Segura-Egea JJ, Sánchez-Margalet V. Role of leptin as a link between metabolism and the immune system. Vol. 35, Cytokine & Growth Factor Reviews. 2017. p. 71–84.
21.
Tsuchiya H, Fujio K. Emerging role of leptin in joint inflammation and destruction. Vol. 45, Immunological Medicine. 2022. p. 27–34.
22.
Achari A, Jain S. Adiponectin, a Therapeutic Target for Obesity, Diabetes, and Endothelial Dysfunction. Vol. 18, International Journal of Molecular Sciences. p. 1321.
23.
Martinez-Huenchullan SF, Tam CS, Ban LA, Ehrenfeld-Slater P, Mclennan SV, Twigg SM. Skeletal muscle adiponectin induction in obesity and exercise. Vol. 102, Metabolism. 2020. p. 154008.
24.
D PS, O Č, V M, B K, D P, V Č. Participation of adinopektin in low affinity inflammation in obese people. p. 1–1121.
25.
de Oliveira dos Santos AR, de Oliveira Zanuso B, Miola VFB, Barbalho SM, Santos Bueno PC, Flato UAP, et al. Adipokines, Myokines, and Hepatokines: Crosstalk and Metabolic Repercussions. Vol. 22, International Journal of Molecular Sciences. p. 2639.
26.
Müller TD, Finan B, Bloom SR, D’Alessio D, Drucker DJ, Flatt PR, et al. Glucagon-like peptide 1 (GLP-1). Vol. 30, Molecular Metabolism. 2019. p. 72–130.
27.
Wu Y, He H, Cheng Z, Bai Y, Ma X. The Role of Neuropeptide Y and Peptide YY in the Development of Obesity via Gut-brain Axis. Vol. 20, Current Protein & Peptide Science. 2019. p. 750–8.
28.
Noor J, Chaudhry A, Batool S, Noor R, Fatima G. Exploring the Impact of the Gut Microbiome on Obesity and Weight Loss: A Review Article. Cureus. 2023.
29.
Isolauri E. Microbiota and Obesity. Intestinal Microbiome: Functional Aspects in Health and Disease. 2017. p. 95–106.
30.
Puljiz Z, Kumric M, Vrdoljak J, Martinovic D, Ticinovic Kurir T, Krnic MO, et al. Obesity, Gut Microbiota, and Metabolome: From Pathophysiology to Nutritional Interventions. Vol. 15, Nutrients. p. 2236.
31.
Powell-Wiley TM, Poirier P, Burke LE, Després JP, Gordon-Larsen P, Lavie CJ, et al. Obesity and Cardiovascular Disease: A Scientific Statement From the American Heart Association. Vol. 143, Circulation. 2021.
32.
Koenen M, Hill MA, Cohen P, Sowers JR. Obesity, Adipose Tissue and Vascular Dysfunction. Vol. 128, Circulation Research. 2021. p. 951–68.
33.
Clayton TL, Fitch A, Bays HE. Obesity and hypertension: Obesity medicine association (OMA) clinical practice statement (CPS) 2023. Vol. 8, Obesity Pillars. 2023. p. 100083.
34.
Parvanova A, Reseghetti E, Abbate M, Ruggenenti P. Mechanisms and treatment of obesity-related hypertension—Part 1: Mechanisms. Vol. 17, Clinical Kidney Journal. 2024.
35.
Koliaki C, Liatis S, Kokkinos A. Obesity and cardiovascular disease: revisiting an old relationship. Vol. 92, Metabolism. 2019. p. 98–107.
36.
D PS, O Č, V Č, B K. Waist circumference as a predictor of atherosclerosis.
37.
Al-Sulaiti H, Diboun I, Agha MV, Mohamed FFS, Atkin S, Dömling AS, et al. Metabolic signature of obesity-associated insulin resistance and type 2 diabetes. Vol. 17, Journal of Translational Medicine. 2019.
38.
Kojta I, Chacińska M, Błachnio-Zabielska A. Obesity, Bioactive Lipids, and Adipose Tissue Inflammation in Insulin Resistance. Vol. 12, Nutrients. p. 1305.
39.
Dutheil F, Gordon BA, Naughton G, Crendal E, Courteix D, Chaplais E, et al. Cardiovascular risk of adipokines: a review. Vol. 46, Journal of International Medical Research. 2018. p. 2082–95.
40.
Su X, Peng D. The exchangeable apolipoproteins in lipid metabolism and obesity. Vol. 503, Clinica Chimica Acta. 2020. p. 128–35.
41.
Seidah NG, Prat A. The Multifaceted Biology of PCSK9. Vol. 43, Endocrine Reviews. 2022. p. 558–82.
42.
Pérez-Torres I, Castrejón-Téllez V, Soto ME, Rubio-Ruiz ME, Manzano-Pech L, Guarner-Lans V. Oxidative Stress, Plant Natural Antioxidants, and Obesity. Vol. 22, International Journal of Molecular Sciences. p. 1786.
43.
D PS, A M, Myeloperoxidase ČV. Activity Study in Obese and Subjects with Metabolic Syndrome. In p. 2021.
44.
Seyedsadjadi N, Grant R. The Potential Benefit of Monitoring Oxidative Stress and Inflammation in the Prevention of Non-Communicable Diseases (NCDs). Vol. 10, Antioxidants. p. 15.
45.
Suren Garg S, Kushwaha K, Dubey R, Gupta J. Association between obesity, inflammation and insulin resistance: Insights into signaling pathways and therapeutic interventions. Vol. 200, Diabetes Research and Clinical Practice. 2023. p. 110691.
46.
Masenga SK, Kabwe LS, Chakulya M, Kirabo A. Mechanisms of Oxidative Stress in Metabolic Syndrome. Vol. 24, International Journal of Molecular Sciences. p. 7898.
47.
Marseglia L, Manti S, D’Angelo G, Nicotera A, Parisi E, Di Rosa G, et al. Oxidative Stress in Obesity: A Critical Component in Human Diseases. Vol. 16, International Journal of Molecular Sciences. p. 378–400.
48.
Gui J, Li Y, Liu H, Guo L lei, Li J, Lei Y, et al. Obesity-and lipid-related indices as a risk factor of hypertension in mid-aged and elderly Chinese: a cross-sectional study. Vol. 24, BMC Geriatrics.
49.
BCLF/BSCL 2021 conference – Sofia. Vol. 36, Biotechnology & Biotechnological Equipment. 2022. p. S22–59.
50.
Yazıcı D, Sezer H. Insulin Resistance, Obesity and Lipotoxicity. Obesity and Lipotoxicity. 2017. p. 277–304.
51.
Fortuño A, Bidegain J, Baltanás A, Moreno MU, Montero L, Landecho MF, et al. Is leptin involved in phagocytic NADPH oxidase overactivity in obesity? Potential clinical implications. Vol. 28, Journal of Hypertension. 2010. p. 1944–50.
52.
López-Acosta O, Cristóbal-García M, Cardoso-Saldaña G, Carvajal-Aguilera K, El-Hafidi M. Smooth Muscle Cells from a Rat Model of Obesity and Hyperleptinemia Are Partially Resistant to Leptin-Induced Reactive Oxygen Species Generation. Vol. 12, Antioxidants. p. 728.
53.
Di Domenico M, Pinto F, Quagliuolo L, Contaldo M, Settembre G, Romano A, et al. The Role of Oxidative Stress and Hormones in Controlling Obesity. Vol. 10, Frontiers in Endocrinology.
54.
Ramezanipour M, Jalali M, Sadrzade-Yeganeh H, Keshavarz SA, Eshraghian MR, Bagheri M, et al. The effect of weight reduction on antioxidant enzymes and their association with dietary intake of vitamins A, C and E. Vol. 58, Arquivos Brasileiros de Endocrinologia & Metabologia. 2014. p. 744–9.
55.
D PS. Koncentracija regulatora apetita i adipocitokina u plazmi adolescenata sa gojaznošću i/ili metaboličkim sindromom. 2018.
56.
Ray A, Bonorden MJL, Pandit R, Nkhata KJ, Bishayee A. Infections and immunity: associations with obesity and related metabolic disorders. Vol. 57, Journal of Pathology and Translational Medicine. 2023. p. 28–42.
57.
Włodarczyk M, Nowicka G. Obesity, DNA Damage, and Development of Obesity-Related Diseases. Vol. 20, International Journal of Molecular Sciences. p. 1146.
58.
Lazarus E, Bays HE. Cancer and Obesity: An Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2022. Vol. 3, Obesity Pillars. 2022. p. 100026.
Citation
Copyright
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Article metrics
Google scholar:
See link
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
